TY - JOUR AU - Baciarello, G. AU - Gizzi, M. AU - Fizazi, K. PY - 2018 DA - 2018// TI - Advancing therapies in metastatic castration-resistant prostate cancer JO - Expert Opin Pharmacother VL - 19 UR - https://doi.org/10.1080/14656566.2018.1527312 DO - 10.1080/14656566.2018.1527312 ID - Baciarello2018 ER - TY - JOUR AU - Qin, Y. AU - Dey, A. AU - Purayil, H. T. AU - Daaka, Y. PY - 2013 DA - 2013// TI - Maintenance of androgen receptor inactivation by S-nitrosylation JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-13-1042 DO - 10.1158/0008-5472.CAN-13-1042 ID - Qin2013 ER - TY - JOUR AU - Zhang, Y. AU - Weinberg, R. A. PY - 2018 DA - 2018// TI - Epithelial-to-mesenchymal transition in cancer: complexity and opportunities JO - Front Med VL - 12 UR - https://doi.org/10.1007/s11684-018-0656-6 DO - 10.1007/s11684-018-0656-6 ID - Zhang2018 ER - TY - JOUR AU - Wade, C. A. AU - Kyprianou, N. PY - 2018 DA - 2018// TI - Profiling prostate Cancer therapeutic resistance JO - Int J Mol Sci VL - 19 UR - https://doi.org/10.3390/ijms19030904 DO - 10.3390/ijms19030904 ID - Wade2018 ER - TY - JOUR AU - Chen, D. AU - Zhou, H. AU - Liu, G. AU - Zhao, Y. AU - Cao, G. AU - Liu, Q. PY - 2018 DA - 2018// TI - SPOCK1 promotes the invasion and metastasis of gastric cancer through Slug-induced epithelial-mesenchymal transition JO - J Cell Mol Med VL - 22 ID - Chen2018 ER - TY - JOUR AU - Song, X. AU - Han, P. AU - Liu, J. AU - Wang, Y. AU - Li, D. AU - He, J. PY - 2015 DA - 2015// TI - Up-regulation of SPOCK1 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma JO - J Mol Histol VL - 46 UR - https://doi.org/10.1007/s10735-015-9627-2 DO - 10.1007/s10735-015-9627-2 ID - Song2015 ER - TY - JOUR AU - Shu, Y. J. AU - Weng, H. AU - Ye, Y. Y. AU - Hu, Y. P. AU - Bao, R. F. AU - Cao, Y. PY - 2015 DA - 2015// TI - SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway JO - Mol Cancer VL - 14 UR - https://doi.org/10.1186/s12943-014-0276-y DO - 10.1186/s12943-014-0276-y ID - Shu2015 ER - TY - JOUR AU - Chen, Q. AU - Yao, Y. T. AU - Xu, H. AU - Chen, Y. B. AU - Gu, M. AU - Cai, Z. K. PY - 2016 DA - 2016// TI - SPOCK1 promotes tumor growth and metastasis in human prostate cancer JO - Drug Des Devel Ther VL - 10 UR - https://doi.org/10.2147/DDDT.S91321 DO - 10.2147/DDDT.S91321 ID - Chen2016 ER - TY - JOUR AU - Yu, F. AU - Li, G. AU - Gao, J. AU - Sun, Y. AU - Liu, P. AU - Gao, H. PY - 2016 DA - 2016// TI - SPOCK1 is upregulated in recurrent glioblastoma and contributes to metastasis and Temozolomide resistance JO - Cell Prolif VL - 49 UR - https://doi.org/10.1111/cpr.12241 DO - 10.1111/cpr.12241 ID - Yu2016 ER - TY - JOUR AU - Zhou, Y. AU - Zheng, J. AU - Li, Y. AU - Xu, D. P. AU - Li, S. AU - Chen, Y. M. PY - 2016 DA - 2016// TI - Natural polyphenols for prevention and treatment of Cancer JO - Nutrients. VL - 8 UR - https://doi.org/10.3390/nu8080515 DO - 10.3390/nu8080515 ID - Zhou2016 ER - TY - JOUR AU - Sak, K. PY - 2014 DA - 2014// TI - Cytotoxicity of dietary flavonoids on different human cancer types JO - Pharmacogn Rev VL - 8 UR - https://doi.org/10.4103/0973-7847.134247 DO - 10.4103/0973-7847.134247 ID - Sak2014 ER - TY - JOUR AU - Xu, L. AU - Zhang, Y. AU - Tian, K. AU - Chen, X. AU - Zhang, R. AU - Mu, X. PY - 2018 DA - 2018// TI - Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects JO - J Exp Clin Cancer Res VL - 37 UR - https://doi.org/10.1186/s13046-018-0929-6 DO - 10.1186/s13046-018-0929-6 ID - Xu2018 ER - TY - JOUR AU - Madunić, J. AU - Madunić, I. V. AU - Gajski, G. AU - Popić, J. AU - Garaj-Vrhovac, V. PY - 2018 DA - 2018// TI - Apigenin: a dietary flavonoid with diverse anticancer properties JO - Cancer Lett VL - 413 UR - https://doi.org/10.1016/j.canlet.2017.10.041 DO - 10.1016/j.canlet.2017.10.041 ID - Madunić2018 ER - TY - JOUR AU - Yan, X. AU - Qi, M. AU - Li, P. AU - Zhan, Y. AU - Shao, H. PY - 2017 DA - 2017// TI - Apigenin in cancer therapy: anti-cancer effects and mechanisms of action JO - Cell Biosci VL - 7 UR - https://doi.org/10.1186/s13578-017-0179-x DO - 10.1186/s13578-017-0179-x ID - Yan2017 ER - TY - JOUR AU - Zhu, Y. AU - Wu, J. AU - Li, S. AU - Wang, X. AU - Liang, Z. AU - Xu, X. PY - 2015 DA - 2015// TI - Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer JO - Mol Med Rep VL - 11 UR - https://doi.org/10.3892/mmr.2014.2801 DO - 10.3892/mmr.2014.2801 ID - Zhu2015 ER - TY - JOUR AU - Chang, J. H. AU - Cheng, C. W. AU - Yang, Y. C. AU - Chen, W. S. AU - Hung, W. Y. AU - Chow, J. M. PY - 2018 DA - 2018// TI - Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses JO - J Exp Clin Cancer Res VL - 37 UR - https://doi.org/10.1186/s13046-018-0869-1 DO - 10.1186/s13046-018-0869-1 ID - Chang2018 ER - TY - JOUR AU - Ganai, S. A. PY - 2017 DA - 2017// TI - Plant-derived flavone Apigenin: the small-molecule with promising activity against therapeutically resistant prostate cancer JO - Biomed Pharmacother VL - 85 UR - https://doi.org/10.1016/j.biopha.2016.11.130 DO - 10.1016/j.biopha.2016.11.130 ID - Ganai2017 ER - TY - JOUR AU - Kuo, T. C. AU - Tan, C. T. AU - Chang, Y. W. AU - Hong, C. C. AU - Lee, W. J. AU - Chen, M. W. PY - 2013 DA - 2013// TI - Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility JO - J Clin Invest VL - 123 UR - https://doi.org/10.1172/JCI64044 DO - 10.1172/JCI64044 ID - Kuo2013 ER - TY - JOUR AU - Chien, M. H. AU - Lee, W. J. AU - Hsieh, F. K. AU - Li, C. F. AU - Cheng, T. Y. AU - Wang, M. Y. PY - 2015 DA - 2015// TI - Keap1-Nrf2 interaction suppresses cell motility in lung adenocarcinomas by targeting the S100P protein JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2880 DO - 10.1158/1078-0432.CCR-14-2880 ID - Chien2015 ER - TY - JOUR AU - Alidadiani, N. AU - Ghaderi, S. AU - Dilaver, N. AU - Bakhshamin, S. AU - Bayat, M. PY - 2018 DA - 2018// TI - Epithelial mesenchymal transition transcription factor (TF): the structure, function and microRNA feedback loop JO - Gene. VL - 674 UR - https://doi.org/10.1016/j.gene.2018.06.049 DO - 10.1016/j.gene.2018.06.049 ID - Alidadiani2018 ER - TY - JOUR AU - Kozlowski, J. M. AU - Fidler, I. J. AU - Campbell, D. AU - Xu, Z. L. AU - Kaighn, M. E. AU - Hart, I. R. PY - 1984 DA - 1984// TI - Metastatic behavior of human tumor cell lines grown in the nude mouse JO - Cancer Res VL - 44 ID - Kozlowski1984 ER - TY - JOUR AU - Parker, C. AU - Nilsson, S. AU - Heinrich, D. AU - Helle, S. I. AU - O'Sullivan, J. M. AU - Fosså, S. D. PY - 2013 DA - 2013// TI - Alpha emitter radium-223 and survival in metastatic prostate cancer JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1213755 DO - 10.1056/NEJMoa1213755 ID - Parker2013 ER - TY - JOUR AU - Templeton, A. J. AU - Dutoit, V. AU - Cathomas, R. AU - Rothermundt, C. AU - Bärtschi, D. AU - Dröge, C. PY - 2013 DA - 2013// TI - Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) JO - Eur Urol VL - 64 UR - https://doi.org/10.1016/j.eururo.2013.03.040 DO - 10.1016/j.eururo.2013.03.040 ID - Templeton2013 ER - TY - JOUR AU - Perlmutter, M. A. AU - Lepor, H. PY - 2007 DA - 2007// TI - Androgen deprivation therapy in the treatment of advanced prostate Cancer JO - Rev Urol VL - 9 ID - Perlmutter2007 ER - TY - JOUR AU - Saraon, P. AU - Drabovich, A. P. AU - Jarvi, K. A. AU - Diamandis, E. P. PY - 2014 DA - 2014// TI - Mechanisms of androgen-independent prostate Cancer JO - EJIFCC. VL - 25 ID - Saraon2014 ER - TY - JOUR AU - Dongre, A. AU - Weinberg, R. A. PY - 2019 DA - 2019// TI - New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer JO - Nat Rev Mol Cell Biol VL - 20 UR - https://doi.org/10.1038/s41580-018-0080-4 DO - 10.1038/s41580-018-0080-4 ID - Dongre2019 ER - TY - JOUR AU - Bradshaw, A. D. PY - 2012 DA - 2012// TI - Diverse biological functions of the SPARC family of proteins JO - Int J Biochem Cell Biol VL - 44 UR - https://doi.org/10.1016/j.biocel.2011.12.021 DO - 10.1016/j.biocel.2011.12.021 ID - Bradshaw2012 ER - TY - JOUR AU - Fan, L. C. AU - Jeng, Y. M. AU - Lu, Y. T. AU - Lien, H. C. PY - 2016 DA - 2016// TI - SPOCK1 is a novel transforming growth factor-β-induced myoepithelial marker that enhances invasion and correlates with poor prognosis in breast Cancer JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0162933 DO - 10.1371/journal.pone.0162933 ID - Fan2016 ER - TY - JOUR AU - Li, Y. AU - Chen, L. AU - Chan, T. H. AU - Liu, M. AU - Kong, K. L. AU - Qiu, J. L. PY - 2013 DA - 2013// TI - SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice JO - Gastroenterology. VL - 144 UR - https://doi.org/10.1053/j.gastro.2012.09.042 DO - 10.1053/j.gastro.2012.09.042 ID - Li2013 ER - TY - JOUR AU - Kim, H. P. AU - Han, S. W. AU - Song, S. H. AU - Jeong, E. G. AU - Lee, M. Y. AU - Hwang, D. PY - 2014 DA - 2014// TI - Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer JO - Oncogene. VL - 33 UR - https://doi.org/10.1038/onc.2013.285 DO - 10.1038/onc.2013.285 ID - Kim2014 ER - TY - JOUR AU - Lo, U. G. AU - Lee, C. F. AU - Lee, M. S. AU - Hsieh, J. T. PY - 2017 DA - 2017// TI - The role and mechanism of epithelial-to-mesenchymal transition in prostate Cancer progression JO - Int J Mol Sci VL - 18 UR - https://doi.org/10.3390/ijms18102079 DO - 10.3390/ijms18102079 ID - Lo2017 ER - TY - JOUR AU - Brown, G. T. AU - Murray, G. I. PY - 2015 DA - 2015// TI - Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis JO - J Pathol VL - 237 UR - https://doi.org/10.1002/path.4586 DO - 10.1002/path.4586 ID - Brown2015 ER - TY - JOUR AU - Aalinkeel, R. AU - Nair, B. B. AU - Reynolds, J. L. AU - Sykes, D. E. AU - Mahajan, S. D. AU - Chadha, K. C. PY - 2011 DA - 2011// TI - Overexpression of MMP-9 contributes to invasiveness of prostate cancer cell line LNCaP JO - Immunol Investig VL - 40 UR - https://doi.org/10.3109/08820139.2011.557795 DO - 10.3109/08820139.2011.557795 ID - Aalinkeel2011 ER - TY - JOUR AU - Alaseem, A. l. i. AU - Alhazzani, K. h. a. l. i. d. AU - Dondapati, P. r. i. y. a. AU - Alobid, S. a. a. d. AU - Bishayee, A. n. u. p. a. m. AU - Rathinavelu, A. p. p. u. PY - 2019 DA - 2019// TI - Matrix Metalloproteinases: A challenging paradigm of cancer management JO - Seminars in Cancer Biology VL - 56 UR - https://doi.org/10.1016/j.semcancer.2017.11.008 DO - 10.1016/j.semcancer.2017.11.008 ID - Alaseem2019 ER - TY - JOUR AU - Zhang, M. AU - Dai, C. AU - Zhu, H. AU - Chen, S. AU - Wu, Y. AU - Li, Q. PY - 2011 DA - 2011// TI - Cyclophilin a promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9 JO - Mol Cell Biochem VL - 357 UR - https://doi.org/10.1007/s11010-011-0909-z DO - 10.1007/s11010-011-0909-z ID - Zhang2011 ER - TY - JOUR AU - Orlichenko, L. S. AU - Radisky, D. C. PY - 2008 DA - 2008// TI - Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development JO - Clin Exp Metastasis VL - 25 UR - https://doi.org/10.1007/s10585-008-9143-9 DO - 10.1007/s10585-008-9143-9 ID - Orlichenko2008 ER - TY - JOUR AU - Miyoshi, A. AU - Kitajima, Y. AU - Sumi, K. AU - Sato, K. AU - Hagiwara, A. AU - Koga, Y. PY - 2004 DA - 2004// TI - Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells JO - Br J Cancer VL - 90 UR - https://doi.org/10.1038/sj.bjc.6601685 DO - 10.1038/sj.bjc.6601685 ID - Miyoshi2004 ER - TY - JOUR AU - Zhang, K. AU - Chen, D. AU - Jiao, X. AU - Zhang, S. AU - Liu, X. AU - Cao, J. PY - 2011 DA - 2011// TI - Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling JO - Lab Investig VL - 91 UR - https://doi.org/10.1038/labinvest.2010.201 DO - 10.1038/labinvest.2010.201 ID - Zhang2011 ER - TY - JOUR AU - Chen, X. J. AU - Wu, M. Y. AU - Li, D. H. AU - You, J. PY - 2016 DA - 2016// TI - Apigenin inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factor-κB/MMP-9 JO - Mol Med Rep VL - 14 UR - https://doi.org/10.3892/mmr.2016.5460 DO - 10.3892/mmr.2016.5460 ID - Chen2016 ER - TY - JOUR AU - He, J. AU - Xu, Q. AU - Wang, M. AU - Li, C. AU - Qian, X. AU - Shi, Z. PY - 2012 DA - 2012// TI - Oral administration of apigenin inhibits metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor model JO - Int J Mol Sci VL - 13 UR - https://doi.org/10.3390/ijms13067271 DO - 10.3390/ijms13067271 ID - He2012 ER - TY - JOUR AU - Toren, P. AU - Zoubeidi, A. PY - 2014 DA - 2014// TI - Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities (review) JO - Int J Oncol VL - 45 UR - https://doi.org/10.3892/ijo.2014.2601 DO - 10.3892/ijo.2014.2601 ID - Toren2014 ER - TY - JOUR AU - Xu, W. AU - Yang, Z. AU - Lu, N. PY - 2015 DA - 2015// TI - A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition JO - Cell Adhes Migr VL - 9 UR - https://doi.org/10.1080/19336918.2015.1016686 DO - 10.1080/19336918.2015.1016686 ID - Xu2015 ER - TY - JOUR AU - Chen, J. AU - Crawford, R. AU - Xiao, Y. PY - 2013 DA - 2013// TI - Vertical inhibition of the PI3K/Akt/mTOR pathway for the treatment of osteoarthritis JO - J Cell Biochem VL - 114 UR - https://doi.org/10.1002/jcb.24362 DO - 10.1002/jcb.24362 ID - Chen2013 ER - TY - JOUR AU - Kwiatkowska, A. AU - Kijewska, M. AU - Lipko, M. AU - Hibner, U. AU - Kaminska, B. PY - 2011 DA - 2011// TI - Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates MMPs expression JO - Biochim Biophys Acta VL - 1813 UR - https://doi.org/10.1016/j.bbamcr.2011.01.020 DO - 10.1016/j.bbamcr.2011.01.020 ID - Kwiatkowska2011 ER - TY - JOUR AU - Fanjul-Fernández, M. AU - Folgueras, A. R. AU - Cabrera, S. AU - López-Otín, C. PY - 2010 DA - 2010// TI - Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models JO - Biochim Biophys Acta VL - 1803 UR - https://doi.org/10.1016/j.bbamcr.2009.07.004 DO - 10.1016/j.bbamcr.2009.07.004 ID - Fanjul-Fernández2010 ER - TY - JOUR AU - Tong, X. i. n. AU - Pelling, J. i. l. l. PY - 2013 DA - 2013// TI - Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention JO - Anti-Cancer Agents in Medicinal Chemistry VL - 13 UR - https://doi.org/10.2174/18715206113139990119 DO - 10.2174/18715206113139990119 ID - Tong2013 ER - TY - JOUR AU - SALMANI, J. u. m. a. h. M. a. s. o. u. d. M. o. h. a. m. m. a. d. AU - ZHANG, X. i. a. o. -. P. i. n. g. AU - JACOB, J. o. e. A. n. t. o. n. y. AU - CHEN, B. a. o. -. A. n. PY - 2017 DA - 2017// TI - Apigenin's anticancer properties and molecular mechanisms of action: Recent advances and future prospectives JO - Chinese Journal of Natural Medicines VL - 15 UR - https://doi.org/10.1016/S1875-5364(17)30052-3 DO - 10.1016/S1875-5364(17)30052-3 ID - SALMANI2017 ER - TY - JOUR AU - Carver, B. S. AU - Chapinski, C. AU - Wongvipat, J. AU - Hieronymus, H. AU - Chen, Y. AU - Chandarlapaty, S. PY - 2011 DA - 2011// TI - Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer JO - Cancer Cell VL - 19 UR - https://doi.org/10.1016/j.ccr.2011.04.008 DO - 10.1016/j.ccr.2011.04.008 ID - Carver2011 ER - TY - JOUR AU - Wang, Y. AU - Mikhailova, M. AU - Bose, S. AU - Pan, C. X. AU - deVere White, R. W. AU - Ghosh, P. M. PY - 2008 DA - 2008// TI - Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival JO - Oncogene. VL - 27 UR - https://doi.org/10.1038/onc.2008.318 DO - 10.1038/onc.2008.318 ID - Wang2008 ER - TY - JOUR AU - Karantanos, T. AU - Corn, P. G. AU - Thompson, T. C. PY - 2013 DA - 2013// TI - Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches JO - Oncogene. VL - 32 UR - https://doi.org/10.1038/onc.2013.206 DO - 10.1038/onc.2013.206 ID - Karantanos2013 ER - TY - JOUR AU - Bellmunt, J. AU - Oh, W. K. PY - 2010 DA - 2010// TI - Castration-resistant prostate cancer: new science and therapeutic prospects JO - Ther Adv Med Oncol VL - 2 UR - https://doi.org/10.1177/1758834009359769 DO - 10.1177/1758834009359769 ID - Bellmunt2010 ER - TY - JOUR AU - Okato, A. AU - Arai, T. AU - Kojima, S. AU - Koshizuka, K. AU - Osako, Y. AU - Idichi, T. PY - 2017 DA - 2017// TI - Dual strands of pre-miR-150 (miR-150-5p and miR-150-3p) act as antitumor miRNAs targetingSPOCK1 in naïve and castration-resistant prostate cancer JO - Int J Oncol VL - 51 UR - https://doi.org/10.3892/ijo.2017.4008 DO - 10.3892/ijo.2017.4008 ID - Okato2017 ER - TY - JOUR AU - Martin, S. K. AU - Pu, H. AU - Penticuff, J. C. AU - Cao, Z. AU - Horbinski, C. AU - Kyprianou, N. PY - 2016 DA - 2016// TI - Multinucleation and mesenchymal-to-epithelial transition alleviate resistance to combined Cabazitaxel and antiandrogen therapy in advanced prostate Cancer JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-2078 DO - 10.1158/0008-5472.CAN-15-2078 ID - Martin2016 ER -